細胞療法市場：細胞タイプ、治療タイプ、用途、エンドユーザー別- 世界予測2024-2030年

細胞療法市場規模は2023年に86億6,000万米ドルと推定され、2024年には96億米ドルに達し、CAGR 10.93％で2030年には179億1,000万米ドルに達すると予測されます。

細胞療法市場には、生きた細胞を投与することで病気の治療、緩和、予防を目的とした製品や技術の研究、開発、製造、商業化が含まれます。再生医療に対する需要の高まりと細胞治療の進歩が、主に細胞療法市場の成長を牽引しています。研究開発への投資が増加し、製薬会社と研究機関の共同努力が細胞療法製品のパイプラインを加速させています。さらに、画期的な治療法に対する支援的な規制の枠組みや迅速な承認の指定は、同市場の重要な成長促進要因となっています。しかし、細胞療法市場は、治療の高コスト、複雑な製造プロセス、市場参入を遅らせる可能性のある厳しい規制要件など、いくつかの制約に直面しています。また、細胞治療の保存、輸送、貯蔵寿命に関する課題も、市場成長の大きな課題となっています。さらに、CRISPR/Cas9のような遺伝子編集技術の飛躍的進歩により、標的細胞療法に新たな道が開かれ、これまで治療不可能だった疾患に対する精密医療ソリューションが提供される可能性があります。細胞療法生産の最適化のための3Dバイオプリンティングと人工知能の採用が増加していることは、将来の市場拡大に大きな期待を抱かせる。

細胞タイプ：治療応用に向けた幹細胞の進歩

分化細胞は、体内で特定の機能を果たすために成熟した特殊な細胞です。分化細胞が細胞療法で使用されるのは、その高い専門性と、失われたり損傷したりした同種の細胞を代替する有効性によるものです。分化細胞の大きな利点は、幹細胞よりも腫瘍形成のリスクが低いことであり、直接的な治療への応用に非常に適しています。幹細胞は、様々な種類の細胞に進化することができる未分化細胞であり、再生医療に大きな可能性を秘めています。幹細胞は特に、自己複製と複数の細胞型への分化というユニークな能力を持つことから、幅広い治療応用に適しています。

治療タイプ：個別化医療のための自家細胞療法の採用増加

同種細胞療法は、遺伝的に異なる健康なドナーの細胞を患者に移植するものです。同種細胞療法は個々の患者に特化したものではなく、大量生産が可能で、しばしば「既製品」と呼ばれます。同種細胞療法は、患者が早急な治療を必要とし、細胞を採取して拡大する時間がない場合に好まれます。自家細胞療法は、患者自身の細胞から得られ、採取され、開発され、必要に応じて改変された後、患者の体内に再導入されます。自己細胞療法は、それぞれの患者さんに合わせて独自に調整されるため、個別化医療の理想的な形態といえます。免疫学的拒絶反応の可能性を排除するため、患者自身の細胞材料を必要とする治療にはしばしば自己細胞療法が選択されます。

用途：細胞治療の皮膚科学的応用の進歩

自己免疫疾患に対する細胞療法は、免疫系を調節またはリセットできる革新的な治療を提供することを目的としています。自己免疫疾患患者は、長期の免疫抑制に伴う副作用を伴わずに、長期的な緩和をもたらす治療法を必要としています。再生細胞療法は、これまで治療の選択肢が限られていた自己免疫疾患の病態に治療法の可能性を提供するものです。皮膚科学における細胞治療の応用は、主に火傷患者の皮膚再生、手術後の再建、慢性創傷、美容的な皮膚の若返りに対処するものです。火傷や慢性創傷に苦しむ患者にとって、細胞療法は治癒を促進し、瘢痕組織の形成を減少させる。皮膚科学と美容への応用は、再生能力を活用して皮膚の外観と健康を改善します。筋骨格系領域における細胞療法は、変形性関節症、骨折、軟骨修復などの症状を対象としています。細胞療法は、損傷した組織を修復・再生するために幹細胞の再生能力を利用することに焦点を当てています。白血病、リンパ腫、多発性骨髄腫などのがん治療において、CAR-Tは画期的なアプローチです。

エンドユーザー：疾病管理のための病院やクリニックにおける細胞治療の多様な用途

バイオテクノロジー企業と製薬企業は、治療ソリューションの開発・提供者として細胞療法市場の主要エンドユーザーです。バイオテクノロジー企業は、がん、自己免疫疾患、遺伝性疾患など様々な疾患に対する細胞療法の発見、開発、商業化に注力しています。細胞科学の進歩、革新的な治療法に対する需要、そして成功した治療法から大きな経済的利益を得られる可能性によって、彼らのニーズに基づいた嗜好が促進されます。病院やクリニックは、患者に細胞療法を実施するために不可欠であるため、市場セグメンテーションのもう一つの重要なセグメントです。特定の細胞療法を好むかどうかは、多くの場合、有効性、安全性プロファイル、費用対効果、償還方針によって決まる。大規模な医療ネットワークや学術機関に属する病院は、院内の専門知識やインフラにより、新規の細胞療法を採用する能力が高い可能性があります。研究機関は、基礎研究とトランスレーショナルリサーチを実施し、このセグメントを発展させることで、エンドユーザーの状況において基本的な役割を果たしています。研究機関は、助成金や内部資金によるプロジェクトを通じて、疾病メカニズムの解明や革新的な治療法の開発に取り組んでいます。

地域別洞察

南北アメリカ地域では、米国とカナダがバイオテクノロジーや製薬大手による大規模な調査、多額の投資、積極的な参加により、細胞療法の進歩をリードしています。この地域の規制的枠組みは、新規細胞治療の迅速な審査を可能にし、新たな治療法の市場投入プロセスを早めています。欧州諸国は、官民を超えた様々なパートナーシップや資金提供プログラムによって、調査に対する協力的なアプローチを示しています。EUの顧客行動は、国費で賄われる医療制度への強い偏見に影響され、細胞治療へのアクセスと手頃な価格に影響を及ぼしています。中東・アフリカでは、イスラエル、アラブ首長国連邦、サウジアラビアのような国々がこのセグメントで飛躍的な進歩を遂げている一方で、アフリカ諸国の多くはまだこのセグメントでの能力を開発中であり、多様な様相を呈しています。アジア太平洋では、中国、インド、日本の政府が、地域の細胞療法研究と商業化を迅速に進めるために、いくつかの投資と改革を開始しています。この地域では、がんや遺伝性疾患の有病率が上昇しており、疾病管理のための細胞ベースの治療に対するニーズが著しく高まっています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは細胞療法市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、細胞療法市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.細胞療法市場の市場規模と予測は？

2.細胞療法市場の予測期間中に投資を検討すべき製品、セグメント、用途、セグメントは何か？

3.細胞療法市場の技術動向と規制枠組みは？

4.細胞療法市場における主要ベンダーの市場シェアは？

5.細胞療法市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオテクノロジーの革新と承認率に対する政府の投資の増加細胞療法
    • 細胞療法サプライチェーンの改善
  • 抑制要因
    • 幹細胞移植に関連する副作用
  • 機会
    • がん治療におけるキメラ抗原受容体T細胞（CAR-T）療法の進歩とESC（胚性幹細胞）とiPSC（人工多能性幹細胞）の利用
    • 神経疾患の治療における幹細胞の利用増加
  • 課題
    • 幹細胞の使用に伴う倫理的問題と薬理学的問題
• 市場セグメンテーション分析
  • 細胞タイプ：治療用途の幹細胞の進歩
  • 治療タイプ：個別化医療における自己細胞療法の採用増加
  • 用途：細胞療法の皮膚科応用の進歩
  • エンドユーザー：病院やクリニックにおける疾病管理のための細胞療法の多様な用途
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 細胞療法市場：細胞タイプ別

• イントロダクション
• 分化細胞
• 幹細胞

第7章 細胞療法市場：治療タイプ別

• イントロダクション
• 同種療法
• 自家療法

第8章 細胞療法市場：用途別

• イントロダクション
• 自己免疫疾患
• 皮膚科
• 筋骨格療法
• 腫瘍学

第9章 細胞療法市場：エンドユーザー別

• イントロダクション
• バイオテクノロジーと製薬企業
• 病院とクリニック
• 研究機関

第10章 南北アメリカの細胞療法市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の細胞療法市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞療法市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. CELL THERAPY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CELL THERAPY MARKET DYNAMICS
• FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 55. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 56. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 57. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 58. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 59. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 63. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 64. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 65. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 66. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 67. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 70. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 71. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 72. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 73. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 74. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 75. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 76. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 77. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 78. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 79. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 80. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 81. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 82. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 83. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 84. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 90. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 92. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 99. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 100. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 101. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 108. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 109. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 110. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 111. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 116. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 117. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 118. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 119. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 124. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 125. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 126. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 127. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 132. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 133. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 134. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 135. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 140. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 141. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 142. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 143. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 148. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 149. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 156. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 157. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 164. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 172. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 173. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 174. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 175. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 180. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 181. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 188. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 189. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 190. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 191. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 205. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 206. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 207. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 212. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 213. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 214. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 215. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 216. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 217. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 222. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 223. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 230. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 231. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 232. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 233. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 236. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 237. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 238. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 239. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 240. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 241. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 246. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 247. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 254. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 255. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 256. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 257. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 262. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 263. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 264. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 265. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 270. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 271. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 278. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 279. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 284. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 285. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 286. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 287. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 288. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 289. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 290. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 291. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 292. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 293. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 294. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 295. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 296. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 297. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 298. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 299. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 300. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 301. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 302. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 303. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 304. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 305. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 306. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 307. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 308. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 310. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 312. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 314. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 316. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 318. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 320. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 322. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 324. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 325. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 326. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 327. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 328. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 329. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 330. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 331. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 332. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 333. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 334. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 335. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 336. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 337. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 338. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 339. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 340. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 341. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 342. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 343. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 344. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 345. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 346. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 347. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 348. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 349. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 350. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 351. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 352. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 353. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 354. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 355. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 356. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 357. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 358. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 359. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 360. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 361. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 362. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 363. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 364. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 365. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 366. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 367. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
• TABLE 368. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
• TABLE 369. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 370. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 371. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 372. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 373. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 374. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

[192 Pages Report] The Cell Therapy Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 9.60 billion in 2024, at a CAGR 10.93% to reach USD 17.91 billion by 2030.

The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques aimed at treating, mitigating, or preventing diseases by administering living cells. The escalating demand for regenerative medicine and advancements in cellular therapeutics primarily drives the growth of the cell therapy market. The rising investment in research and development and collaborative efforts between pharmaceutical companies and research institutions have accelerated the pipeline for cell therapy products. Furthermore, supportive regulatory frameworks and the designation of fast-track approvals for groundbreaking therapies have been crucial growth stimulants for the market. However, the cell therapy market faces several limitations, such as the high cost of therapies, intricate manufacturing processes, and stringent regulatory requirements, which may slow down market entry. Issues related to the preservation, transport, and shelf-life of cell therapies also present substantial challenges in the market growth. Moreover, breakthroughs in gene editing technologies such as CRISPR/Cas9 have opened new avenues for targeted cell therapies, which could offer precision medicine solutions for previously untreatable conditions. The increasing adoption of 3D bioprinting and artificial intelligence for optimizing cell therapy production holds significant promise for future market expansion.

Cell Type: Advancements in stem cells for therapeutic applications

Differentiated cells are specialized cells that have matured to perform a specific function in the body. Differentiated cells are used in cell therapy due to their high specialization and efficacy in replacing lost or damaged cells of the same type. The significant advantage of differentiated cells lies in their lower risk of tumor formation than stem cells, making them highly preferable for direct therapeutic applications. Stem cells are undifferentiated cells that can evolve into various types of cells and hold enormous potential for regenerative medicine. Stem cells are particularly used for their unique capabilities to self-renew and differentiate into multiple cell types, making them suitable for a broad range of therapeutic applications.

Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines

Allogeneic cell therapies involve transplanting cells from a healthy, genetically different donor into a patient. Allogeneic cell therapies are not specific to the individual patient and can be manufactured in larger batches, often called "off-the-shelf" products. Allogeneic therapies are preferred when patients require immediate treatment and do not have time to harvest and expand their cells. Autologous cell therapies are derived from the patient's own cells, which are collected, developed, modified if needed, and then reintroduced into the patient's body. Autologous cell therapies are uniquely tailored to each patient, making them an ideal form of personalized medicine. Autologous therapies are often the choice for treatments requiring the patient's own cellular material to eliminate chances of immunological rejection.

Application: Advancements in dermatological applications of cell therapies

Cell therapies for autoimmune diseases aim to provide innovative treatments that can modulate or reset the immune system. Autoimmune patients require treatments that can provide long-term relief without the adverse effects associated with long-term immunosuppression. Regenerative cell therapies offer potential cures for autoimmune disease conditions that previously had limited treatment options. The application of cell therapies in dermatology primarily addresses skin regeneration for burn victims, reconstruction following surgery, chronic wounds, and cosmetic skin rejuvenation. For patients suffering from burns or chronic wounds, cell therapies accelerate healing and reduce scar tissue formation. Dermatological & cosmetic applications leverage regenerative capabilities to improve skin appearance and health. Cell therapies in the musculoskeletal domain target conditions such as osteoarthritis, bone fractures, and cartilage repair. Cell therapies focus on harnessing the regenerative potential of stem cells for repair and regenerate damaged tissues. Cell therapy plays a critical role in oncology, with CAR-T cell therapy being a revolutionary approach in cancer treatment, including leukemia, lymphoma, and multiple myeloma.

End-User: Diverse applications of cell therapies in hospitals and clinics for disease management

Biotechnology and pharmaceutical companies are primary end-users in the cell therapy market as developers and providers of therapeutic solutions. Biotechnology companies focus on the discovery, development, and commercialization of cell therapies for a variety of diseases, including cancer, autoimmune disorders, and genetic diseases. Their need-based preference is driven by advancements in cellular science, the demand for innovative treatments, and the potential for significant financial returns from successful therapies. Hospitals and clinics represent another crucial segment in the cell therapy market, as they are essential for administering cell therapies to patients. The preference for specific cell therapies often depends on efficacy, safety profiles, cost-effectiveness, and reimbursement policies. Hospitals affiliated with large healthcare networks or academic institutions may have a greater capacity for adopting novel cell therapies due to in-house expertise and infrastructure. Research institutes serve a fundamental role in the cell therapy end-user landscape by conducting basic and translational research to advance the field. Research institutes seek to understand disease mechanisms and develop innovative therapies through grant-funded or internally-financed projects.

Regional Insights

In the Americas region, the United States and Canada lead in cell therapy advancements, driven by significant research, heavy investment, and active participation from biotechnological and pharmaceutical giants. The regulatory framework in the region allows for an expedited review of novel cell therapies, hastening up the process of bringing new treatments to market. The European countries exhibit a cooperative approach towards cell therapy research, with various cross-country partnerships and funding programs supported by public and private sectors. Customer behavior in the EU is influenced by a strong predisposition towards state-funded healthcare systems, which affects access to and affordability of cell therapies. The Middle East and Africa (MEA) present a diverse picture, with countries such as Israel, UAE, and Saudi Arabia taking strides in cell therapy, while many African nations are still developing capabilities in this area. In the APAC region, the governments in China, India, and Japan have initiated several investments and reforms to fast-track local cell therapy research and commercialization. The rising prevalence of cancers and genetic diseases in the region is significantly increasing the need for cell-based therapies for disease management.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Astellas Pharma Inc., Athersys, Inc., BioNTech SE, Bone Therapeutics SA, Bristol-Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., Lonza Group Ltd., Medipost Co., Ltd., Mesoblast Ltd., Novartis AG, NuVasive, Inc., Pfizer Inc., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, TegoScience, Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Cell Type
  • Differentiated Cell
  • Stem Cell

• Therapy Type
  • Allogenic Therapies
  • Autologous Therapies

• Application
  • Autoimmune Diseases
  • Dermatology
  • Musculoskeletal Therapies
  • Oncology

• End-User
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
  • Research Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Market?

4. What is the market share of the leading vendors in the Cell Therapy Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
    • 5.1.1.2. Improvements in Cell Therapy Supply Chain
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects Related to the Stem Cell Transplant
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
    • 5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
  • 5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
  • 5.2.3. Application: Advancements in dermatological applications of cell therapies
  • 5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Cell Therapy Market, by Cell Type

• 6.1. Introduction
• 6.2. Differentiated Cell
• 6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type

• 7.1. Introduction
• 7.2. Allogenic Therapies
• 7.3. Autologous Therapies

8. Cell Therapy Market, by Application

• 8.1. Introduction
• 8.2. Autoimmune Diseases
• 8.3. Dermatology
• 8.4. Musculoskeletal Therapies
• 8.5. Oncology

9. Cell Therapy Market, by End-User

• 9.1. Introduction
• 9.2. Biotechnology and Pharmaceutical Companies
• 9.3. Hospitals and Clinics
• 9.4. Research Institutes

10. Americas Cell Therapy Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Therapy Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Pluri Launches New Cell Therapy CDMO Division
  • 13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
  • 13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio